Nuvilex, an international biotech company providing cell and
gene therapy solutions for the treatment of diseases, recently held three days
of meetings set up to cement the company’s objectives, strategy, and plans for
future research and development.
The meeting agenda called for heavy emphasis on the
preparation for late-phase clinical trials of Nuvilex, which will use the
recently acquired Cell-in-a-Box™ technology as part of the treatment for those
suffering from advanced, inoperable pancreatic cancer. Nuvilex acquired the
rights to this technology from SG Austria; the license for its use in diabetes
was acquired by Nuvilex from Austrianova Singapore.
Also on the discussion table was the potential role that the
live-cell encapsulation technology might play in developing treatments for
diabetes, as well as in the development of treatments for diseases using active
compounds derived from marijuana.
Meeting participants included the officers and board of
directors of Nuvilex, as well as principals professor Walter H. Gunzburg,
chairman and chief technical officer of SG Austria, and Dr. Brian Salmons, CEO
and president of Austrianova Singapore.
Drs. Gunzburg and Salmons developed and brought to maturity
the cellulose-based live-cell encapsulation technology that is the basis for
Nuvilex’s research and development efforts. The doctors were also directly
involved in the successful phase 1/2 clinical trials in advanced, inoperable
pancreatic cancer already conducted using this technology.
Drs. Gunzburg and Salmons will continue to work closely with
the company in projects that involve the use of this technology.
“These meetings were important and essential in cementing
our plans for developing treatments for serious and deadly diseases like cancer
and diabetes through the use of the cellulose-based live cell encapsulation
technology,” Kenneth L Waggoner, Nuvilex’s CEO and president, stated in the
news release. “In that vein, we are extremely grateful to Drs. Gunzburg and
Salmons for traveling from Singapore to join us in them and for agreeing to
work closely with us in our efforts to employ the technology that they have
developed.”
For more information, visit www.nuvilex.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment